financetom
Business
financetom
/
Business
/
Navan, Inc. (NAVN) Shares Slide Amid Surprise Sales & Marketing Expense Increase Coincident with IPO, Securities Class Action Pending – Hagens Berman
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Navan, Inc. (NAVN) Shares Slide Amid Surprise Sales & Marketing Expense Increase Coincident with IPO, Securities Class Action Pending – Hagens Berman
Mar 17, 2026 4:03 PM

SAN FRANCISCO, March 17, 2026 (GLOBE NEWSWIRE) -- A securities class action lawsuit has been filed against Navan, Inc. ( NAVN ) , its IPO underwriters, and certain executives after the company’s December 15, 2025 announcement of Q3 2026 quarterly financial results for the quarter ended October 31, 2025. Among other matters, investors learned that Navan incurred a huge sequential increase in sales and marketing expenses.

Of concern was that the quarter end coincided with Navan’s IPO closing, whereby the company and certain selling stockholders sold about 36.9 million shares at $25 per share to the investing public.

Navan also announced the surprise departure of its CFO (Amy Butte) effective January 9, 2026.

The markets swiftly reacted, sending the price of Navan shares down nearly 12% to close at $12.90, or about 48% below the IPO price, on December 16. By the time the complaint was filed on February 23, 2026, the price of Navan shares closed at $9.16, or 63% below the IPO price.

The developments and severe market reactions have prompted national shareholder rights law firm Hagens Berman to investigate the legal claims that Navan and the other defendants violated the federal securities laws. The firm urges Navan investors who suffered significant losses to contact the firm now to discuss their rights.

Class Period: Oct. 28, 2025 – Feb. 23, 2026

Lead Plaintiff Deadline: Apr. 24, 2026

Visit: www.hbsslaw.com/investor-fraud/navn

Contact the Firm Now: [email protected]844-916-0895

Navan, Inc. ( NAVN ) Securities Class Action:

The litigation challenges Navan’s alleged omissions from its IPO offering documents, including adverse, then-existing trends in sales and marketing expenses.

The complaint alleges that Navan’s IPO offering documents offered a picture of potential growth by emphasizing that its business “experienced rapid growth,” and its solutions catered to “customers of all sizes across any industry vertical.” The IPO documents stated Navan’s revenue “grew 33% year-over-year” from 2024 to 2025, its gross booking volume (“GBV”) “grew 32% year-over-year” during the same timeframe, and its “usage yield” was “approximately 7%” in each of those years as well.

But, when on December 15, 2025, Navan unexpectedly reported a 39% sequential spike in its sales and marketing expenses during the IPO-coincident quarter ended October 31, 2025, slowing year-over-year revenue growth, and a fourfold year-over-year increase in its GAAP net loss, questions arose about the sufficiency of Navan’s disclosures, including those related to its Q3 expense trends, while conducting its IPO.

The complaint alleges that Navan’s and the other defendants’ statements and omissions during the IPO misled investors because crucial information – including the spike in sales and marketing expenses – was not included in the company’s offering documents.

“We’re investigating whether, at the time of its IPO, Navan was legally transparent about apparently known, materially adverse trends in its business. We’re also investigating the circumstances surrounding the CFO’s abrupt departure,” said Reed Kathrein, the Hagens Berman partner leading the firm’s investigation.

If you invested in Navan and have substantial losses, or have knowledge that may assist the firm’s investigation, submit your losses now.

If you’d like more information and answers to additional frequently asked questions about the case and the firm’s Navan investigation, read more.

Whistleblowers: Persons with non-public information regarding Navan should consider their options to help in the investigation or take advantage of the SEC Whistleblower program. Under the new program, whistleblowers who provide original information may receive rewards totaling up to 30 percent of any successful recovery made by the SEC. For more information, call Reed Kathrein at 844-916-0895 or email [email protected].

About Hagens Berman

Hagens Berman is a global plaintiffs’ rights complex litigation firm focusing on corporate accountability. The firm is home to a robust practice and represents investors as well as whistleblowers, workers, consumers and others in cases achieving real results for those harmed by corporate negligence and other wrongdoings. Hagens Berman’s team has secured more than $2.9 billion in this area of law. More about the firm and its successes can be found at hbsslaw.com. Follow the firm for updates and news at @ClassActionLaw.

Contact:

Reed Kathrein, 844-916-0895

Image: https://www.globenewswire.com/newsroom/ti?nf=OTY3NDAzMyM3NDkxMDAyIzIwMTg1MzI=

Image: https://ml.globenewswire.com/media/MzFlMDQ4YmEtMGFjMy00YmU5LTg2ZTktMDRjNzA0ODdlODE5LTEwMzAxMDUtMjAyNi0wMy0xNy1lbg==/tiny/Hagens-Berman-Sobol-Shapiro-LL.png Image: Primary Logo

Source: Hagens Berman Sobol Shapiro LLP

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Once a beacon of stability, Vietnam to name third president in a year
Once a beacon of stability, Vietnam to name third president in a year
Mar 22, 2024
HANOI, March 22 (Reuters) - Communist-ruled Vietnam is seeking its third president in little more than a year after the resignation of Vo Van Thuong, who was only elected last year after the sudden dismissal of his predecessor. With accumulated foreign direct investment higher than its gross domestic product, Vietnam's stability is crucial to multinationals with large operations in the...
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Mar 22, 2024
05:04 AM EDT, 03/22/2024 (MT Newswires) -- Hutchmed ( HCM ) said late Thursday it has started the registration stage for a phase 2/3 clinical trial of investigational drug sovleplenib for adult patients with warm antibody autoimmune hemolytic anemia in China. The move follows positive data from the proof-of-concept phase 2 stage of the trial and a consultation with the...
Japan's union group Rengo announces biggest wage hikes on record
Japan's union group Rengo announces biggest wage hikes on record
Mar 22, 2024
TOKYO (Reuters) -Japanese firms have agreed to raise pay by 5.25% this year, the biggest rise under comparable data since 2013, the country's largest union group Rengo confirmed on Friday. The results of the closely-watched wage negotiations are announced in several stages, in which the blue-chip firms are first to wrap up their talks in mid-March. The second announcement on...
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Mar 22, 2024
(Reuters) - Popular investor Cathie Wood's ARK Invest bought nearly 10,000 shares of Reddit ( RDDT ) in the social media platform's strong market debut on Thursday, an email from the asset manager showed. A total of 9,982 shares of the loss-making company was added to ARK Next Generation Internet ETF ( ARKW ) and ARK Fintech Innovation ETF (...
Copyright 2023-2026 - www.financetom.com All Rights Reserved